© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Kanamycin disulfate stands out in the class of aminoglycoside antibiotics, widely used to combat bacterial infections across clinical settings and research labs. Its molecular structure features the formula C18H38N4O15S, giving it a unique balance of potency and stability. I have seen its white to slightly yellow crystalline powder become a familiar sight on the shelf of any microbiology laboratory, its texture often resembling fine granules or light fluffy flakes. Researchers often store it in containers labeled by its molecular weight, 582.58 g/mol, along with its unmistakable solid physical state and slight solubility in water. HS Code 29419090 classifies it for transport and regulation, marking it as a raw material for pharmaceuticals and diagnostics.
The compound’s physical behavior carries practical implications for storage, handling, and experimentation. Kanamycin disulfate gives off a faint odor and offers strong solubility in water, yielding clear or slightly turbid solutions when dissolved to laboratory concentrations. The crystalline solid resists melting until exposed to relatively high heat, a property rooted in its network of hydrogen bonds. With a density averaging 1.69 g/cm3, it disperses evenly in aqueous media and can be weighed out either as pearls, small flakes, or fine powders. Consistency in solid form allows technicians to dose with precision — a vital concern for antibiotic efficacy and safety. Liquid and solution formulations exist as well, with careful preparation to maintain stability and ensure the compound’s antimicrobial action remains reliable during use.
The aminoglycoside backbone defines Kanamycin disulfate’s molecular structure, bringing together sugar groups and amine functionalities. Sulfate ions improve solubility and enhance compatibility with biological buffers. The raw material’s purity affects everything from the reliability of experimental results to the safety profile in medical treatments. Having handled antibiotic powders in both research and industrial environments, I know firsthand the importance of clear hazard labeling. Kanamycin disulfate can irritate skin and eyes on contact and poses risks through inhalation or accidental ingestion. It demands gloves, goggles, and lab coats, with good ventilation on hand, not because of rare accidents but due to frequent, real-world incidents that highlight the occupational risks of chemical handling. Safety data sheets, which detail material hazards and first aid protocols, keep teams prepared — a core principle in any operation where this chemical comes into play.
Pharmaceutical manufacturers lean on Kanamycin disulfate because the compound delivers broad-spectrum action against a range of bacteria, especially strains resistant to other drugs. Scientists use it to create selective environments in culture media, as its mechanism disrupts bacterial protein synthesis by binding to the 30S ribosomal subunit. This specificity underpins its valuable role as a selection agent in genetic engineering, where only bacteria harboring a kanamycin resistance gene survive, streamlining cloning projects. Specifications require a high purity grade, usually exceeding 98%, minimal moisture content, and strict thresholds for heavy metals or other contaminants. The compound comes in varying particle sizes — from microcrystalline solids to coarse powders — which I can say directly affects ease of measurement and solution preparation. Each batch ties back to traceable documentation and analytical reports, meeting regulatory standards that protect end-users from unforeseen variables.
Discarded antibiotics like Kanamycin disulfate create environmental hazards once they enter wastewater streams. Persistent residues drive antimicrobial resistance in soil and water microbiomes, a crisis that resonates for anyone tracking public health trends. Facilities mitigate risks by employing controlled waste management, neutralizing spent solutions through chemical digestion or incineration. I’ve seen universities and biotech companies set up dedicated hazardous waste systems not just to meet compliance requirements, but to address the real-world harm of pollution and resistance transfer. Material handlers benefit from clear protocols: segregate Kanamycin waste, label it correctly, and move it through secure chemical disposal workflows. This attention to detail addresses the persistent insecurities about pharmaceuticals in our natural and urban habitats, keeping both ecosystems and human populations safer.
Knowing the true properties of Kanamycin disulfate, from chemical formula to hands-on safety requirements, means more than reading off a data sheet. It means understanding the texture, the risks, and the responsibilities of working with a compound that has saved lives but also challenges us with real safety and environmental burdens. Taking every aspect into account — HS code, specific density, structure as a solid, powder, or flakes, chemical safety labeling, and raw material purity — leads to decisions that matter whether in a research lab, a pharmaceutical plant, or an environmental monitoring station. Investment in safe handling, rigorous specification adherence, and ethical waste management isn’t just good practice. It’s something every scientist and industrial user owes to public health and to the next person who picks up that white bottle of Kanamycin disulfate.
